|
ALG10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.776100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.998600E-01 |
| Normal-vs-Stage2 |
4.460400E-01 |
| Normal-vs-Stage3 |
6.803100E-03 |
| Normal-vs-Stage4 |
3.616600E-03 |
| Stage1-vs-Stage2 |
6.267000E-01 |
| Stage1-vs-Stage3 |
3.303900E-03 |
| Stage1-vs-Stage4 |
3.440500E-03 |
| Stage2-vs-Stage3 |
1.450830E-01 |
| Stage2-vs-Stage4 |
1.072010E-01 |
| Stage3-vs-Stage4 |
7.754000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.968000E-02 |
| Normal-vs-AfricanAmerican |
1.898600E-03 |
| Normal-vs-Asian |
7.540600E-01 |
| Caucasian-vs-AfricanAmerican |
1.899790E-02 |
| Caucasian-vs-Asian |
8.125400E-01 |
| AfricanAmerican-vs-Asian |
2.184200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.530100E-02 |
| Normal-vs-Female |
3.088000E-01 |
| Male-vs-Female |
1.792360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.160900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.581200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.799600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.716500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.446200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.405770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.823600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.593030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.852160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.139200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.884200E-01 |
| Normal-vs-Grade 2 |
8.992800E-01 |
| Normal-vs-Grade 3 |
1.777960E-02 |
| Normal-vs-Grade 4 |
3.61110000000053E-05 |
| Grade 1-vs-Grade 2 |
6.845600E-01 |
| Grade 1-vs-Grade 3 |
1.503000E-01 |
| Grade 1-vs-Grade 4 |
9.255700E-03 |
| Grade 2-vs-Grade 3 |
4.700900E-03 |
| Grade 2-vs-Grade 4 |
2.11829999999802E-05 |
| Grade 3-vs-Grade 4 |
6.341600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.059000E-01 |
| Normal-vs-ccB subtype |
1.115750E-02 |
| ccA subtype-vs-ccB subtype |
1.351870E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.652000E-01 |
| Normal-vs-N1 |
4.770000E-02 |
| N0-vs-N1 |
1.798970E-01 |
|
|
